Dr. Raj Patil is Sr. Director of Research & Development at OKYO Pharma speaks to Zak Mir. Dr. Patil brings more than 25 years of academic and pharmaceutical experience in Ophthalmology and inflammatory diseases.
OKYO Pharma Limited (LSE: OKYO) is a biopharmaceutical company developing next-generation therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. Our goal is to develop first in class drug candidates that prevent the disease instead of controlling it, and we achieve this through our collaboration with pioneer scientists in the field.
All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned